News Swedish Orphan Biovitrum AB

Equities

SOBI

SE0000872095

Real-time Estimate Cboe Europe Other stock markets 06:14:28 2024-04-26 am EDT			5-day change	1st Jan Change
278.6 ^SEK	-0.78%		+6.74%	+4.34%

Apr. 25	Transcript : Swedish Orphan Biovitrum AB, Q1 2024 Earnings Call, Apr 25, 2024
Apr. 25	Swedish Orphan Biovitrum AB Reports Earnings Results for the First Quarter Ended March 31, 2024	CI

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Sobi establishes MTN programme with a framework amount of SEK 10 billion, publishes a base prospectus	04:31am	AQ
Swedish Orphan Biovitrum : 25 april - Q1 2024 rapport	Apr. 25	PU
Transcript : Swedish Orphan Biovitrum AB, Q1 2024 Earnings Call, Apr 25, 2024	Apr. 25
Swedish Orphan Biovitrum : 25 April - Q1 2024 report	Apr. 25	PU
Sobi Q1 2024 report: Strong sales reflecting the strength of the portfolio	Apr. 25	AQ
Swedish Orphan Biovitrum AB Reports Earnings Results for the First Quarter Ended March 31, 2024	Apr. 25	CI
Invitation: Sobi's Q1 2024 report	Apr. 15	PU
Notice of Annual General Meeting in Swedish Orphan Biovitrum AB (publ)	Apr. 04	AQ
Swedish Orphan Biovitrum : Sobi publishes Annual and sustainability report for 2023	Apr. 02	PU
Sobi publishes Annual and sustainability report for 2023	Apr. 02	AQ
Swedish Orphan Biovitrum : Sobi announces positive results from phase 3 study of Doptelet® for treatment of children and adolescents with ITP	Mar. 25	PU
Certain Shares of Swedish Orphan Biovitrum AB are subject to a Lock-Up Agreement Ending on 14-MAR-2024.	Mar. 13	CI
Sobi to Expand in South Korea via Rare Disease JV with Handok	Feb. 13	MT
US Futures, European Stocks Mixed	Feb. 12	DJ
Orexo, Swedish Orphan Biovitrum to Further Explore AmorphOX Combination	Feb. 12	MT
Orexo AB (Publ.) and Swedish Orphan Biovitrum AB (publ.) Agrees to Advance Feasibility Study with Amorphox	Feb. 12	CI
Sobi's Growth Potential Remains 'Tremendous' Amid Conservative FY24 Outlook, RBC Says	Feb. 09	MT
Transcript : Swedish Orphan Biovitrum AB, Q4 2023 Earnings Call, Feb 08, 2024	Feb. 08
Sobi publishes Q4 2023 report: Strong revenue performance and growth into 2024	Feb. 08	AQ
Swedish Orphan Biovitrum AB Provides Revenue Guidance for the Year 2024	Feb. 08	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Swedish Orphan Biovitrum AB

Equities

SOBI

SE0000872095

Summary

Filters